Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism.

[1]  C. Kennedy,et al.  PGE2 reduces arachidonic acid release in murine podocytes: evidence for an autocrine feedback loop. , 2003, American journal of physiology. Cell physiology.

[2]  B. Baggio.  Fatty acids, calcium and bone metabolism. , 2002, Journal of nephrology.

[3]  R. Gibson,et al.  Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio. , 2002, Journal of lipid research.

[4]  H. Weiler,et al.  Modulation of essential (n-6):(n-3) fatty acid ratios alters fatty acid status but not bone mass in piglets. , 2002, The Journal of nutrition.

[5]  P. Calder.  Dietary modification of inflammation with lipids , 2002, Proceedings of the Nutrition Society.

[6]  I. Otterness,et al.  Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. , 2002, Arthritis and rheumatism.

[7]  E. Schwarz,et al.  Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. , 2002, The Journal of clinical investigation.

[8]  P. Albertazzi,et al.  Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention? , 2002, Maturitas.

[9]  B. Baggio,et al.  Fatty acids and cytokine mRNA expression in human osteoblastic cells: a specific effect of arachidonic acid. , 2002, Clinical science.

[10]  U. Das.  Nitric Oxide as the Mediator of the Antiosteoporotic Actions of Estrogen, Statins, and Essential Fatty Acids , 2002, Experimental biology and medicine.

[11]  J. Woo,et al.  Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro. , 2002, Biochemical pharmacology.

[12]  E. Birch,et al.  Essential fatty acids in visual and brain development , 2001, Lipids.

[13]  B. Watkins,et al.  Omega-3 Polyunsaturated Fatty Acids and Skeletal Health1 , 2001, Experimental biology and medicine.

[14]  S. Rhee,et al.  Saturated Fatty Acids, but Not Unsaturated Fatty Acids, Induce the Expression of Cyclooxygenase-2 Mediated through Toll-like Receptor 4* , 2001, The Journal of Biological Chemistry.

[15]  B. Boyan,et al.  Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways. , 2001, Biomaterials.

[16]  T. Stone,et al.  Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders , 2001, British Journal of Nutrition.

[17]  M. F. Seifert,et al.  Bioactive fatty acids: role in bone biology and bone cell function. , 2001, Progress in lipid research.

[18]  P. Zannini,et al.  Effect of endogenous and exogenous prostaglandin E(2) on interleukin-1 beta-induced cyclooxygenase-2 expression in human airway smooth-muscle cells. , 2000, American journal of respiratory and critical care medicine.

[19]  B. Watkins,et al.  Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. , 2000, The Journal of nutrition.

[20]  D. Reid,et al.  Evidence for a Pathogenic Role of Nitric Oxide in Inflammation‐Induced Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  M. Kruger,et al.  Oestrogen and essential fatty acid supplementation corrects bone loss due to ovariectomy in the female Sprague Dawley rat. , 1999, Prostaglandins, leukotrienes, and essential fatty acids.

[22]  K. Tanne,et al.  Influence of dietary n-3 polyunsaturated fatty acid on experimental tooth movement in rats. , 1999, The Angle orthodontist.

[23]  B. Watkins,et al.  Dietary Conjugated Linoleic Acids Alter Serum IGF‐I and IGF Binding Protein Concentrations and Reduce Bone Formation in Rats Fed (n‐6) or (n‐3) Fatty Acids , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  B. Boyan,et al.  Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner. , 1999, Bone.

[25]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[26]  P. Marie.  Cellular and molecular alterations of osteoblasts in human disorders of bone formation. , 1999, Histology and histopathology.

[27]  K. Suzuki,et al.  Long-term effects of prostaglandin E2 on the mineralization of a clonal osteoblastic cell line (MC3T3-E1). , 1999, Archives of oral biology.

[28]  S. Endres,et al.  Lipid treatment of inflammatory bowel disease. , 1999, Current opinion in clinical nutrition and metabolic care.

[29]  G. Gericke,et al.  Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis , 1998, Aging.

[30]  E. Birch,et al.  Visual Acuity and the Essentiality of Docosahexaenoic Acid and Arachidonic Acid in the Diet of Term Infants , 1998, Pediatric Research.

[31]  D. Chang,et al.  Reduction in Transforming Growth Factor β Receptor I Expression and Transcription Factor CBFa1 on Bone Cells by Glucocorticoid* , 1998, The Journal of Biological Chemistry.

[32]  R. Bockman,et al.  Activators of protein kinase A decrease the levels of free arachidonic acid in osteoblasts via stimulation of phosphatidylcholine and phosphatidylethanolamine synthesis. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[33]  L. Cleland,et al.  Dietary n-3 fatty acids and therapy for rheumatoid arthritis. , 1997, Seminars in arthritis and rheumatism.

[34]  D. Horrobin,et al.  Calcium metabolism, osteoporosis and essential fatty acids: a review. , 1997, Progress in lipid research.

[35]  G. Atsumi,et al.  Prostaglandin E2 Amplifies Cytosolic Phospholipase A2- and Cyclooxygenase-2-dependent Delayed Prostaglandin E2 Generation in Mouse Osteoblastic Cells , 1997, The Journal of Biological Chemistry.

[36]  G. Stein,et al.  Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone‐specific complex , 1997, Journal of cellular biochemistry.

[37]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[38]  Heather J Barker,et al.  Incorporation of long-chain n-3 fatty acids in tissues and enhanced bone marrow cellularity with docosahexaenoic acid feeding in post-weanling Fischer 344 rats , 1997, Lipids.

[39]  M. Hirafuji,et al.  Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. , 1997, Prostaglandins, leukotrienes, and essential fatty acids.

[40]  S Tamai,et al.  In vitro bone formation by rat marrow cell culture. , 1996, Journal of biomedical materials research.

[41]  J. Hibbeln,et al.  Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. , 1995, The American journal of clinical nutrition.

[42]  M. Kruger,et al.  The effect of different n-6/n-3 essential fatty acid ratios on calcium balance and bone in rats. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.

[43]  D. van Papendorp,et al.  Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. , 1995, Bone.

[44]  U. Suchner,et al.  Immune modulation by polyunsaturated fatty acids during nutritional therapy: interactions with synthesis and effects of eicosanoids. , 1994, Infusionstherapie und Transfusionsmedizin.

[45]  S. Narumiya,et al.  VIII. International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes , 1994 .

[46]  M. Hirafuji,et al.  Role of endogenous PGE2 in osteoblastic functions of a clonal osteoblast-like cell, MC3T3-E1. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[47]  I. Morita,et al.  Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. , 1994, Prostaglandins, leukotrienes, and essential fatty acids.

[48]  Subburaman Mohan,et al.  Growth factors to stimulate bone formation , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[50]  W. Lands.  Eicosanoids and Health , 1993, Annals of the New York Academy of Sciences.

[51]  R. Wuthier.  Involvement of cellular metabolism of calcium and phosphate in calcification of avian growth plate cartilage. , 1993, The Journal of nutrition.

[52]  J. Aubin,et al.  β‐Glycerophosphate‐induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[53]  L. Quarles,et al.  Distinct proliferative and differentiated stages of murine MC3T3‐E1 cells in culture: An in vitro model of osteoblast development , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[54]  J. Kanis,et al.  Involvement of prostaglandin E2 in the inhibition of osteocalcin synthesis by human osteoblast-like cells in response to cytokines and systemic hormones. , 1990, Biochemical and biophysical research communications.

[55]  C. McCulloch,et al.  Effects of donor age on osteogenic cells of rat bone marrow in vitro , 1990, Mechanisms of Ageing and Development.

[56]  D. B. Evans,et al.  The effects of recombinant human interleukin-1 beta on cellular proliferation and the production of prostaglandin E2, plasminogen activator, osteocalcin and alkaline phosphatase by osteoblast-like cells derived from human bone. , 1990, Biochemical and biophysical research communications.

[57]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[58]  O. H. Lowry,et al.  The quantitative histochemistry of the retina. , 1956, The Journal of biological chemistry.

[59]  O. H. Lowry,et al.  The quantitative histochemistry of brain. II. Enzyme measurements. , 1954, The Journal of biological chemistry.

[60]  J. Kremer.  n-3 fatty acid supplements in rheumatoid arthritis. , 2000, The American journal of clinical nutrition.

[61]  S. Narumiya,et al.  Prostaglandin E2 (PGE2) Autoamplifies its Production Through EP1 Subtype of PGE Receptor in Mouse Osteoblastic MC3T3-E1 Cells , 1998, Calcified Tissue International.

[62]  S. Miller,et al.  Prostaglandins and the skeleton: The legacy and challenges of two decades of research , 1993 .

[63]  Gardiner Pj.  Classification of prostanoid receptors. , 1990, Advances in prostaglandin, thromboxane, and leukotriene research.

[64]  K. Shichikawa,et al.  A longitudinal population survey of rheumatoid arthritis in a rural district in Wakayama. , 1981, Ryumachi. [Rheumatism].

[65]  R. Holman,et al.  Polyunsaturated fatty acids , 1977 .